View All

Lilly’s COVID-19 antibody reduces hospitalization rate; Tiny biologic drug to combat COVID-19; Aziyo Biologics files for $57.5 M IPO; BMS exercises option on Obsidian’s CD40L cell therapy

Lilly links COVID-19 antibody to a reduce hospitalization rate Eli Lilly has linked its anti-SARS-CoV-2 antibody to a lower rate of hospitalization in patients lately diagnosed with mild to moderate cases of COVID-19. Nevertheless, two of the three doses, including the highest studied in the phase 2 trial, flunk...

Find More

Coronavirus (COVID-19)
Should you wear contact lenses amid coronavirus outbreak?

The novel coronavirus since its outbreak in China November last year has now spread internationally. As per the latest updates, the Coronavirus (CoVID-19) has spread across 159 countries, with the death toll of 7,529 and confirmed cases reaching to 184,975 as on March 18. Several health organizations such as the WH...

Find More

Questions and Answers on the Novel Coronavirus Disease (COVID-19)

What is a Coronavirus? Coronavirus are a large group of viruses that are known for causing respiratory infections or diseases ranging from as normal as the common cold to life-threading epidemics like SARS, and MERS. What is COVID-19? COVID-19 is a novel infection caused by novel Coronavirus now termed as...

Find More

Coronavirus (COVID- 19)
The epidemic now has a name: COVID-19

Amid the breakout in Wuhan, China, the novel coronavirus has managed to invade the other countries across the globe. Till now, almost 25 countries including several Asian, northern American, Australia and European countries, have reported confirmed cases of coronavirus. With the infected cases totalling to 4...

Find More